A phase I/II study of neoadjuvant chemotherapy with Pemetrexed (Alimta) in rectal cancer

Preoperative (Neoadjuvant) treatment with Pemetrexed was feasible in studied patients. Serious side effects were limited and a radiological tumour response or stable disease was seen in a majority of patients.